A
Power Law company profile
Aprogen
Biotech & Life Sciences · Seongnam-si, South Korea · Founded 2000 Unicorn
Global footprint
Where Aprogen has talent and traffic
Web traffic by country
86K
monthly visits
across markets
across markets
🏳️ Korea99.5%
🏳️ Republic of0%
Patent intelligence
$23M patent portfolio · 18 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$23M
2.3% of valuation · 2.7× smaller than top peer Sirna Therapeutics ($63M)
18 active patent families
Where Aprogen innovates
Nucleic acid moleculeMolecular biologyAntigenAntibodyMonoclonal antibody
Above peer median on Legal · Below peer median on Market
Quality vs same-sector peers
Aprogen on the five Patsnap quality dimensions
Aprogen in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Aprogen concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Aprogen and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Aprogen on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.